Skip to main content
. 2022 Jun 20;28(10):1380–1386. doi: 10.1016/j.jiac.2022.06.010

Table 2.

Laboratory characteristics of the study groups.

Parameters Normal range (units) Total (n = 555) Mild - moderate (n = 459) Severe/critical (n = 96) p-value
WBC count (median, IQR) 4.0–12.0 (x103/μL) 8.2 (6.1–11.1) 8.1 (6.2–10.9) 8.8 (5.8–11.8) 0.67
Neutrophil count 3.0–5.8 (x103/μL) 3.2 (1.8–5.4) 3.0 (1.8–5.0) 3.9 (2.1–7.4) 0.004
Lymphocyte count 1.5–3.0 (x103/μL) 3.3 (2.0–4.8) 3.4 (2,1–4.8) 2.8 (1.8–4.6) 0.05
Platelet count (median, IQR) 150–400 (x103/μL) 280 (215–353) 287 (220–355) 248 (193–332) 0.05
CRP (median, IQR) <5 (mg/L) 3.3 (0.7–14.2) 2.6 (0.7–10.6) 8.6 (1–56.8) <0.001
CRP > 20 mg/L (n, %) 100 (18.0) 61 (13.3) 39 (40.6) < 0.001
Ferritin (median, IQR) 6–60 (μg/L) 251.7 (84.3–542) 166.8 (67.6–443) 488.6 (271.5–783.4) <0.001
Elevated ferritin (n, %) 400 (72.1) 311 (67.8) 89 (92.7) < 0.001
E gene Ct value (mean ± variance) 22.6 ± 7.1 22.2 ± 7.1 24.5 ± 6.9 0.01
Total (n = 146) Moderate (n = 50) Severe/critical (n = 96)
AST (median, IQR) 1560 (U/L) 55.5 (43.589.7) 45.7 (3860.3) 60.5 (48103.7) 0.001
ALT (median, IQR) 13–45 (U/L) 31.7 (22.4–51.4) 28.3 (21–38.1) 37 (22.7–69.8) 0.02
Creatinine (median, IQR) 35.0–62.0 (μmol/L) 42.7 (35.1–51.9) 36.6 (32–42.2) 46.0 (38.6–53.8) <0.001
PT (median, IQR) 13.1–16.3 (s) 13.6 (12.4–15.2) 13.2 (12.3–14.4) 13.8 (12.6–15.6) 0.07
PT > 18s (n, %) 17 (11.6) 4 (8) 13 (13.5) 0.42
aPTT (median, IQR) 28.6–35.8 (s) 34.1 (30.7–39.4) 35.5 (31.3–39.5) 33.2 (30.5–38.7) 0.58
aPTT > 44s (n, %) 17 (11.6) 5 (10) 12 (12.5) 0.66
Fibrinogen (median, IQR) 2.03–3.77 (g/L) 3.1 (2.4–4.3) 3.7 (2.9–4.5) 2.9 (2.3–4.0) 0.009
D-dimer (median, IQR) 0.09–0.53 (μg/mL) 0.9 (0.63–1.78) 0.72 (0.56–1.12) 1.14 (0.67–2.17) 0.02
D-dimer > 5ULN (n, %) 27 (18.5) 6 (12) 21 (21.9) 0.15

WBC: white blood cell, CRP: C-reactive protein, Ct: Cycle threshold.

AST: aspartate aminotransferase; ALT: alanine aminotransferase; PT: prothrombin time; aPTT: activated partial thromboplastin time.